Peptide therapies are quickly gaining momentum in the wellness and medical sectors, with demand across the globe expected to exceed $71 billion by 2030
Think of it as a cellular battery
Per HumeCare's Medications Safety Information, the most commonly reported side effects are typically mild and tend to resolve after the first several weeks of treatment: nausea, vomiting, diarrhea, constipation, abdominal pain, upset stomach, abdominal distension, reflux, headache, fatigue, and dizziness
Nonetheless, sustained cognitive effort affected GSH levels, and, once more, this effect was region dependent
[DOI] [PubMed] [Google Scholar] 91.Seki S., Kitada T., Yamada T., Sakaguchi H., Nakatani K., Wakasa K